PROGNOSTIC VALUE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO AT DIAGNOSIS IN COLORECTAL CANCER: PROPENSITY SCORE ANALYSIS
David Ortiz López,Joaquín Marchena Gómez,Eva María Nogués Ramia,Yurena Sosa Quesada,Beatriz Arencibia Pérez,Manuel Artiles Armas,Julia Gil García,Cristina Roque Castellano
DOI: https://doi.org/10.17235/reed.2024.10041/2023
2024-01-01
Revista Española de Enfermedades Digestivas
Abstract:INTRODUCTION: Baseline neutrophil-to-lymphocyte ratio (NLR) at the time of colorectal cancer (CRC) diagnosis has been proposed as a predictor of long-term survival. The aim of the study was to analyse its usefulness in a homogeneous population with control of the main confounding factors.METHODOLOGY: Observational study of 836 patients operated on for CRC who were divided into two groups: NLR ≤ 3.3 vs NLR > 3.3. To control for confounders, they were matched one-to-one by propensity analysis. A final sample of 526 patients remained for study.RESULTS: The two groups were mismatched in terms of age, comorbidity, tumour stage, rectal location, and neoadjuvant therapy. Once matching was performed, baseline NLR was statistically significantly associated with long-term survival (p < 0.001) and behaved as an independent prognostic factor for survival (p = 0.001; HR: 1,996; 95% CI: 1.32-3.00) when adjusted in a Cox regression model using age (p < 0,001; HR: 1,04; IC95%: 1,02-1,06) and the Charlson Comorbidity Index (p < 0,001; HR: 1,40; IC95%: 1,27-1,55). Neoadjuvant therapy lost its statistical significance (p = 0,137; HR: 1,59; IC95%: 0,86-2,93).CONCLUSIONS: A high baseline NLR (> 3.3) in patients with colorectal cancer at diagnosis represents a poor prognostic factor in terms of survival. Its use in routine practice could intensify therapeutic strategies and follow-up in these patients.
gastroenterology & hepatology